BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33529259)

  • 1. Early differences in dynamic uptake of 68Ga-PSMA-11 in primary prostate cancer: A test-retest study.
    Olde Heuvel J; de Wit-van der Veen BJ; Sinaasappel M; Slump CH; Stokkel MPM
    PLoS One; 2021; 16(2):e0246394. PubMed ID: 33529259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-phase 68Ga-PSMA-11 PET/CT may increase the rate of detected lesions in prostate cancer patients.
    Dadgar H; Seyedi Vafaee M; Norouzbeigi N; Jafari E; Gholamrezanezhad A; Assadi M
    Urologia; 2021 Nov; 88(4):355-361. PubMed ID: 33627056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-PSMA SPECT/CT Versus 68Ga-PSMA PET/CT in the Evaluation of Metastatic Prostate Cancer.
    Fallahi B; Khademi N; Karamzade-Ziarati N; Fard-Esfahani A; Emami-Ardekani A; Farzanefar S; Eftekhari M; Beiki D
    Clin Nucl Med; 2021 Feb; 46(2):e68-e74. PubMed ID: 33234922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality.
    Singh B; Sharma S; Bansal P; Hooda M; Singh H; Parihar AS; Kumar A; Watts A; Mohan R; Singh SK
    Nucl Med Commun; 2021 May; 42(5):482-489. PubMed ID: 33395191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.
    Uprimny C; Kroiss AS; Fritz J; Decristoforo C; Kendler D; von Guggenberg E; Nilica B; Maffey-Steffan J; di Santo G; Bektic J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1647-1655. PubMed ID: 28589253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early dynamic imaging in
    Uprimny C; Kroiss AS; Decristoforo C; Fritz J; Warwitz B; Scarpa L; Roig LG; Kendler D; von Guggenberg E; Bektic J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):765-775. PubMed ID: 27900519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental Value of Post Diuretic 68Ga-PSMA-11 PET-CT in Characterization of Indeterminate lLesions in Prostate Cancer.
    Ghadanfer L; Usmani S; Marafi F; Al-Kandari F; Rasheed R
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3719-3723. PubMed ID: 33369473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis.
    Hu X; Wu Y; Yang P; Wang J; Wang P; Cai J
    Int Braz J Urol; 2022; 48(6):891-902. PubMed ID: 34003611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between Prostate Cancer Positive Cores and 68Ga-PSMA Distribution in Prostate Gland.
    Çankaya S; Caylan AE; Aydin F; Uçar M; Kutlu Ö
    Urol Int; 2024; 108(1):65-72. PubMed ID: 38016433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate Cancer.
    Park SY; Zacharias C; Harrison C; Fan RE; Kunder C; Hatami N; Giesel F; Ghanouni P; Daniel B; Loening AM; Sonn GA; Iagaru A
    Radiology; 2018 Aug; 288(2):495-505. PubMed ID: 29786490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Early Dynamic Positron Emission Tomography/Computed Tomography Obviate the Need for Postdiuresis Image in
    Perveen G; Arora G; Damle NA; Prabhu M; Arora S; Tripathi M; Bal C; Kumar P; Kumar R; Singh P; Das CJ; Passah A
    Indian J Nucl Med; 2018; 33(3):202-208. PubMed ID: 29962715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
    van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
    BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging.
    Demirci E; Sahin OE; Ocak M; Akovali B; Nematyazar J; Kabasakal L
    Nucl Med Commun; 2016 Nov; 37(11):1169-79. PubMed ID: 27333090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.
    Prasad V; Steffen IG; Diederichs G; Makowski MR; Wust P; Brenner W
    Mol Imaging Biol; 2016 Jun; 18(3):428-36. PubMed ID: 27038316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Time Point for 68Ga-PSMA-11 PET/CT Imaging in the Assessment of Suspected Metastatic Prostate Cancer in the Bladder of Postprostatectomy Patient.
    Xu G; Lu Y
    Clin Nucl Med; 2021 Aug; 46(8):675-676. PubMed ID: 33577202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of early imaging with
    Özülker F
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):100-105. PubMed ID: 30514659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Early Dynamic Positron Emission Tomography/Computed Tomography with 68Ga-prostate-specific Membrane Antigen-HBED-CC in Patients with Adenocarcinoma Prostate: Initial Results.
    Perveen G; Arora G; Damle NA; Prabhu M; Arora S; Tripathi M; Bal C; Kumar P; Kumar R; Singh P
    Indian J Nucl Med; 2018; 33(2):112-117. PubMed ID: 29643670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Early and Late [
    Hohberg M; Kobe C; Täger P; Hammes J; Schmidt M; Dietlein F; Wild M; Heidenreich A; Drzezga A; Dietlein M
    Mol Imaging Biol; 2019 Jun; 21(3):558-566. PubMed ID: 30105521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Time-Point 68Ga-PSMA I&T PET/CT for Characterization of Primary Prostate Cancer: Value of Early Dynamic and Delayed Imaging.
    Schmuck S; Mamach M; Wilke F; von Klot CA; Henkenberens C; Thackeray JT; Sohns JM; Geworski L; Ross TL; Wester HJ; Christiansen H; Bengel FM; Derlin T
    Clin Nucl Med; 2017 Jun; 42(6):e286-e293. PubMed ID: 28221194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.